FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
Saved in:
Published in: | Haematologica (Roma) Vol. 106; no. 1; pp. 250 - 254 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Italy
Fondazione Ferrata Storti
01-01-2021
Ferrata Storti Foundation |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Bibliography: | SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 Disclosures: Yulia Lin has received research funding from Novartis and Octapharma and consulting fees from Amgen and Pfizer. Alan H. Lazarus has patents on the use of monoclonal antibodies as replacements for IVIg and has received research funding from Rigel Pharmaceuticals Incorporated and CSL Behring. GBS, WRB, UJS, BB, SNL-T, CMC-G, GV, JC, DB, RK, and JWS do not have relevant conflicts on interest to disclose. Contributions: AHL, GBS and PAAN conceived the study; PAAN, AHL, GBS, and R.K. designed experiments; WRB, UJS, SNL-T, GV, BB, CMC-G JC, YL, Dand JWS provided reagents; PAAN performed experiments; AHL, GB and PAAN analyzed and interpreted data; PAAN and GBS wrote the manuscript; AHL, GBS, PAAN, WRB, UJS, SNL-T, GV, JC, RK and JWS edited the manuscript. |
---|---|
ISSN: | 0390-6078 1592-8721 |
DOI: | 10.3324/haematol.2020.248385 |